原发性甲状腺B细胞淋巴瘤的克隆演化与复发分子机制
本研究通过突变谱分析10例原发性甲状腺B细胞淋巴瘤,包括5例异时性淋巴瘤、1例复合淋巴瘤和4例伴甲状腺炎活检的淋巴瘤,发现多数复发病例源于克隆相关前体细胞的分化演化,部分为原发淋巴瘤进展或EMZL转化。
要点
- 甲状腺淋巴瘤复发多源于克隆相关前体细胞的分化演化。
- 复合淋巴瘤中EBV阳性DLBCL可由EMZL转化而来。
- 部分淋巴瘤与甲状腺炎活检共享突变,提示前体细胞参与。
核心结论
- 甲状腺淋巴瘤复发可能频繁通过克隆相关前体细胞的分化演化发生,该前体细胞可能为癌前病变。
研究设计与样本
- 对10例原发性甲状腺B细胞淋巴瘤进行突变谱分析,包括5例异时性淋巴瘤(原发EMZL 4例、DLBCL 1例;局部复发EMZL 3例、DLBCL 2例)、1例复合EMZL和EBV阳性DLBCL、4例伴先前或后续甲状腺炎活检的淋巴瘤(EMZL 3例、FL 1例)。
主要发现
- 4例异时性淋巴瘤的配对病变中可见共享和不同变异,提示从克隆相关前体细胞分化演化。
- 1例异时性淋巴瘤的复发病变由原发淋巴瘤进展而来。
- 1例复合淋巴瘤中EBV阳性DLBCL由EMZL转化而来。
- 4例伴甲状腺炎活检的病例中,2例配对病变共享突变,提示克隆相关前体细胞参与和分化演化。
临床怎么用
- 对甲状腺淋巴瘤复发患者,应考虑克隆相关前体细胞分化演化的可能,需结合突变谱分析评估克隆关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary thyroid lymphomas comprise largely extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (EMZL) and diffuse large B-cell lymphoma (DLBCL), followed by follicular lymphoma (FL). They commonly develop from a background of Hashimoto's thyroiditis (HT), where dysregulated immune responses trigger autoreactive infiltrates and drive clonal B-cell evolution. To understand how these lymphomas and their relapse evolve, we investigated 10 cases by mutation profiling, including five with metachronous lymphomas [primary lymphoma (EMZL = 4, DLBCL = 1) with local relapse (EMZL = 3, DLBCL = 2)], one composite EMZL and Epstein-Barr virus (EBV)-positive DLBCL, and four lymphomas (EMZL = 3, FL = 1) with prior or subsequent biopsy showing HT. In four cases with metachronous lymphomas, both common and distinct variants were seen in the paired lesions, indicating their divergent evolution from clonally related lymphoma precursor (CLP) cells. In the remaining case with metachronous lymphomas, the relapsed lesion was progressed from the initial lymphoma. In the case with composite lymphoma, the EBV-positive DLBCL was transformed from EMZL. Finally, in the four cases with paired lymphoma and HT biopsies, two showed shared mutations between the paired lesions, indicating involvement and divergent evolution from CLP cells. Thyroid lymphoma relapse may frequently develop via divergent evolution from a CLP cell, which is likely premalignant. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
引用
- Tzioni MM, Watanabe N, Chen Z, et al. Primary thyroid B-cell lymphoma: molecular insights into its clonal evolution and relapse. J Pathol. 2024. PMID: 39722652. doi:10.1002/path.6380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。